Chr. Hansen Holding A/S appoints new Executive Vice President and Chief Scientific Officer

Chr. Hansen Holding A/S appoints new Executive Vice President and Chief Scientific Officer
Thomas Schäfer
Press Release | Dec 06. 2016 14:18 GMT

Chr. Hansen Holding A/S has entered into an agreement with Thomas Schäfer to take up the position of Executive Vice President and Chief Scientific Officer.

Thomas is currently employed as Vice President at Novozymes and will take up his new position as soon as possible, expected during the spring of 2017.He will report to the CEO and become a member of the Executive Board.

A German national, Thomas completed his Ph.D. in Microbiology, Physiology & Biochemistry and worked as Assistant Professor at Freie Universität Berlin. He started his career in Novozymes as a PostDoc in 1994 and has held various senior leadership positions in the R&D space in Novozymes since. Since 2013 Thomas has been based in the US.

Thomas has more than 20 years of experience in Industrial Microbiology, R&D, Innovation, Business Development and Mergers & Acquisitions, covering both bacteria and enzymes, and he has published several papers, and he is also the co-inventor on a number of patents.

Thomas will lead Chr. Hansen’s scientific organization for Food Cultures and Enzymes, and for Health and Nutrition (the R&D organization for the Microbial Solutions Platform). This organization consists of 210 employees, largely based at company headquarters in Denmark. Currently the core activities are organized in 5 departments: Discovery, Development, Process, Analytics and Resource & Planning.

Including Thomas Schäfer into the Executive Board is a signal of the importance Chr. Hansen places on its innovation and science as an area critical in securing continuous growth. Thomas brings extensive experience from various disciplines and segments in the scientific space.

“In hiring Thomas, Chr. Hansen brings onboard a very skilled and business-oriented technology leader with international experience. The overall goal of the R&D Microbial Platform is to secure a common and strong scientific backbone within industrial microbes that can sustain new innovations for the Food Cultures & Enzymes and Health & Nutrition Business Units and support Chr. Hansen’s undisputed leadership in bacterial fermentation technology. I am happy to welcome Thomas to the Executive Board”, says CEO Cees de Jong.

“I really look forward to joining Chr. Hansen. I have followed the fantastic growth of this company for many years, so it is great to become a part of the journey”, says Thomas Schäfer.

Once Thomas has joined, the Executive Board will consist of: CEO Cees de Jong, CFO Søren Westh Lonning, COO Knud Vindfeldt, and CSO Thomas Schäfer.


For media inquiries:
Camilla Lercke, Head of Media Relations DKCALE@chr-hansen.com, Tel: +45 53 39 23 84

For investor relations:
Anders Mohr Christensen, Vice President, Investor Relations DKAMC@chr-hansen.com, Tel: +45 45 74 76 18


Chr. Hansen est une entreprise internationale, leader dans le domaine de la bioscience, qui met au point des solutions naturelles pour les industries des secteurs alimentaire, nutritionnel, pharmaceutique et agricole. Nous développons et produisons des cultures, des enzymes, des probiotiques et des colorants naturels pour toute une série d'aliments, de bonbons, de boissons, de compléments alimentaires, de produits alimentaires pour animaux, ainsi que de produits de protection des plantes. Notre innovation en matière de produits repose sur environ 40 000 souches microbiennes – que nous aimons appeler de « bonnes bactéries ». Nos solutions permettent aux fabricants de produits alimentaires de produire plus avec moins – tout en limitant le recours à des produits chimiques ou à des additifs de synthèse – ce qui rend nos produits très intéressants dans le monde actuel. Le développement durable fait partie intégrante de la vision de Chr. Hansen pour améliorer l'alimentation et la santé. En 2019, Chr. Hansen a été classée l’entreprise la plus durable au monde par Corporate Knights grâce à ses efforts soutenus en matière de développement durable et à ses nombreux partenariats collaboratifs avec ses clients. Nous apportons de la valeur à nos partenaires et, au final, aux consommateurs du monde entier, et ce depuis plus de 145 ans. Nous sommes fiers que plus d'un milliard de personnes dans le monde consomment des produits contenant nos ingrédients naturels tous les jours. La société Chr. Hansen a été fondée en 1874 et est cotée au Nasdaq de Copenhague.

Partager